You have read all your free articles, to continue reading subscribe to read the rest of this content.
Danish Forward Pharma A/S has announced the pricing of its initial public offering of 10,500,000 American Depositary Shares, ADSs. The ADSs represent the biopharmaceutical's ordinary shares at a price to the public of USD 21.00 per ADS. The share were expected to begin trading on October 15 on thAlready a…
Through the Directed Share Issue, Cantargia will receive proceeds amounting to approximately SEK 410 million before transaction related costs. Investors in the Directed Share Issue are a wide range of Swedish and international investors including new investors such as Swedbank Robur, HBM HealthcaAlready a subscriber Login You have read all…
Exact Therapeutics announces that its shares have been admitted to trading on Oslo Stock Exchange’s Merkur Market under the ticker EXTX-ME with first day of trading 14 July 2020, following the successful completion of a NOK 155 million private placement. Following a bookbuilding period from 4 -Already a subscriber Login…
The Danish biotech company has been awarded an investment of 3.6 mEUR from the Novo Holdings REPAIR Impact Fund for development of therapies to combat antimicrobial resistance (AMR). An additional investment of 0.8 mEUR was obtained from SunStone Capital. The funding will be used to help finalizeAlready a subscriber Login…
